Constitutive telomerase activity maintains telomere length and confers immortal phenotypes to human cancers. The prevalence of telomerase, rather than a homologous recombination-based mechanism, in telomere length maintenance suggests that telomerase also has auxiliary roles in tumorigenesis. Here, we investigate growth advantages provided by the telomerase enzyme in oncogene-transformed human cells that do not require telomerase activity for telomere length control. Our data suggest that in oncogene-transformed cells, telomerase activity accelerates cell growth kinetics in a cell cycle phase-specific manner and promotes anchorage-independent growth. Coculture experiments demonstrated that this growth advantage conferred by telomerase activity is not due to increased cellular cross-talk. Growth advantages provided by telomerase required all functional aspects of the enzyme. Dissociation-of-activity-in-telomerase mutants and other functionally defective versions of telomerase were unable to promote oncogene-transformed cell growth, suggesting that canonical telomerase activities may be involved. We conclude that telomerase provides advantages to oncogene-transformed human cells, thereby supporting the development of telomerasebased anticancer chemotherapies targeting these growthpromoting effects.
Introduction
Telomerase is a ribonucleoprotein complex responsible for the de novo synthesis of telomere repeats (Morin, 1989) . Telomerase functions as a reverse transcriptase, copying a six-nucleotide sequence from its internal RNA template (telomerase RNA, TER) to the ends of chromosomes. Telomerase activity is mostly absent in adult somatic cells in human, therefore telomeres shorten as cells proliferate .
Eventually, telomeres become critically short and induce proliferative senescence, a tumor-suppressive mechanism that limits the accumulation of deleterious mutations that can contribute to cellular transformation. To circumvent this limit on proliferation and achieve immortal growth, human tumors over-ride the transcriptional inhibition of telomerase reverse transcriptase (TERT) to constitutively restore the expression of telomerase (Janknecht, 2004; Blasco, 2005) . High telomerase activity is observed in over 85% of human cancers (Shay and Bacchetti, 1997) . In contrast, a small proportion of human tumors utilize the alternate lengthening of telomere (ALT) mechanism, a non-physiological, homologous recombination-based system to maintain telomeres (Bryan et al., 1995 (Bryan et al., , 1997 . ALT is a relatively rare mechanism, detected in a small number of human tumors of non-epithelial origin and in transformed fibroblasts in culture (Bryan et al., 1997; Fasching et al., 2005) .
Human primary fibroblasts were transformed to malignant tumor cells when introduced to a minimum of three defined genetic elements, including TERT, simian virus 40 early region containing the SV40 large T antigen and the small T antigen, as well as the Ras oncogene (Hahn et al., 1999a) . Functionally, Ras provides an oncogenic signal to promote cellular proliferation and growth (Hurlin et al., 1987) , and SV40LT inactivates both p53 and Rb tumor suppression pathways, thereby reversing their growth inhibition activities (Jha et al., 1998) . SV40ST forms a complex with the serine-threonine protein phosphatase 2A family of proteins. These phosphatases have diverse functions in the regulation of multiple protein kinase cascades that are implicated in cell growth and proliferation (Chen and Hahn, 2003; Chen et al., 2004) . TERT expression and telomerase activation are believed to prevent the proliferative arrest brought on by telomere attrition (Bodnar et al., 1998) . Although SV40LT inhibitory activity on the p53 and Rb tumor suppressor pathways are adequately replaced by similar p53 and Rb inhibitory activities, with the expression of human papillomavirus E6 and E7 oncoproteins (Kiyono et al., 1998) , telomere maintenance by the ALT mechanism is unable to replace TERT expression and promote robust tumorigenesis in nude mice. This implies that the role of telomerase activity in cancer development goes beyond telomere maintenance (Stewart et al., 2002) .
Several studies have reported on the non-telomere maintenance roles of telomerase and related these activities to the prevalence of TERT expression in tumor samples (Sharma et al., 2003; Masutomi et al., 2005) . Forced telomerase expression in primary human mammary epithelial cells reduces their requirement for exogenous mitogens to sustain cellular proliferation. mRNA expression profiles of these cells have correlated the reduction in exogenous growth factor dependency with the induction of gene expression that promotes cell growth and survival (Smith et al., 2003) . A similar study using human foreskin fibroblasts also revealed telomerase-dependent induction of the expression of growthpromoting cytokines such as epiregulin (Lindvall et al., 2003) . Studies of mice with genetically deficient TER support the non-canonical role of TERT as a transcriptional coactivator in the absence of TER. TERT expression in mouse skin caused a rapid transition of hair follicles from the telogen phase (quiescence) to the anagen phase (active growth), resulting in robust hair growth. This effect is associated with the growthpromoting gene expression programs related to the activation of c-myc and wnt transcriptional pathways (Choi et al., 2008; Park et al., 2009) .
Corroborating the idea that telomerase contributes to cancer growth beyond telomere length maintenance, telomerase was found to regulate chromatin states and DNA-damage response in primary fibroblasts . Low levels of endogenous telomerase expression were found in primary fibroblasts, but this activity did not support stable telomere maintenance. However, when this endogenous telomerase expression was disrupted by RNA interference, an early exit from the cell cycle into quiescent senescence was observed (Masutomi et al., 2003) . Knocking down the low-level endogenous TERT expression in primary fibroblasts affected the overall configuration of chromatin, increased fibroblast sensitivity to ionizing radiation and resulted in a diminished capacity to repair genomic DNA damaged by exposure to ionizing radiation. These defects were rescued by the expression of a recombinant form of TERT, but were not rescued by a catalytically inert TERT mutant . Dissociation-of-activity-in-telomerase (DAT) mutants of TERT, which are catalytically active but cannot support telomere maintenance, also competently restored DNA-damage protection (Armbruster et al., 2001; Banik et al., 2002) . Overall, these results suggest that telomerase activity is required for more than just telomere synthesis for cell survival and proliferation.
Here, to examine how telomerase expression may contribute to the improved growth and survival of human cells with inactivated growth inhibitory signals, we expressed telomerase components in three different ALT cell models. The ALT cell prototype, WI-38 primary-fibroblast-derived VA13 subtype, maintains telomere length in the absence of TERT and TER. The VA13 subtype was created with SV40 transformation, which inactivates the tumor suppressors p53 and Rb (Tokutake et al., 1998) , and alters signal transduction pathways regulated by the phosphatase family of PP2A. The recombinant expression replacement of TERT and TER in this cell line does not result in the loss of ALT phenotypes, indicating that ALT and telomerase-dependent telomere maintenance can coexist (Cerone et al., 2001) . As telomere length maintenance can be completely uncoupled from telomerase action in ALT cells, we can specifically test the growth-promoting functions of telomerase and compare them with the parental isogenic VA13 cell controls expressing empty retroviral vector. Similar strategies of telomerase activity expression were adopted with an additional two human ALT cell models. Using these models, we measured the distinct contribution of recombinant telomerase expression to the fitness of oncogenetransformed human cells.
Results
Telomerase confers growth advantages in ALT cells. This effect is dependent on both TERT and TER Telomerase components were stably expressed by retroviral infection in three ALT cell models, VA13, SUSM-1 and GM00847. Telomerase activity was measured using the telomere repeat amplification protocol (TRAP). As expected, robust telomerase activity was reconstituted in VA13 cells following the expression of both TERT and TER, but not either component alone. In addition to VA13, described in the introduction, SUSM-1 cells were derived from human primary fibroblasts AD387 by treatment with 4-nitro-quinoline-1-oxide (Ogata et al., 1993) . SUSM-1, like VA13, did not show any expression of TERT or TER. GM00847 cells are SV-40 transformed primary skin fibroblasts. This cell line has normal expression of TER but does not express any TERT (Wong et al., 2002) . As shown by the TRAP assay, recombinant expression of both TERT and TER components were necessary to restore telomere synthesis in SUSM-1 cells. In contrast, the recombinant expression of TERT alone was sufficient to restore positive TRAP signals in GM00847 cells, as GM00847 cells constitutively express TER from the endogenous locus ( Figure 1 ). Telomere restriction fragment analysis revealed long and heterogeneous telomere signals (Supplementary Figure 1) , and the presence of ALTassociated promyelocytic leukemia bodies were not affected by forced telomerase expression (Supplementary Figure 2 ). As we confirmed the maintenance of these two molecular signatures of ALT cells following forced telomerase expression, we concluded that the presence of telomerase activity did not affect the ALT mechanism of telomere maintenance.
Forced expression of telomerase activity confers growth advantages in ALT cells under regular cell culture conditions or under highly diluted seeding ratios. This growth advantage is seen in ALT cells with reconstituted telomerase activity but not in cells expressing either the TERT or TER component alone. Analysis of the growth curves revealed a modest, but consistent, increase in the population-doubling rate, which continued until the cells reached confluency in the tissue culture vessels (Figure 2) . We also performed a serial limited dilution experiment to test the ability of GM00847 cells to repopulate the culture vessels when seeded with decreasing amounts of starting cells. Telomerase expression in GM00847 cells conferred a clear advantage in every concentration of seeding tested (Figure 3a) .
To demarcate the increased growth rate in telomerasepositive ALT cells from the ability to repopulate a culture vessel with a small starting cell number, we repeated the low seeding number experiment with VA13 Figure 1 Construction of telomerase-expressing ALT cells. Whole-cell extracts from each ALT cell line, expressing either TERT alone, TER alone or both components together, were normalized according to protein concentration and assayed for telomerase activity using the telomere repeat amplification protocol (TRAP). Telomerase activity was reconstituted in VA13 and SUSM-1 cells expressing both TERT and TER components together, but not either subunit alone. In contrast, TERT expression without recombinant TER in GM00847 cells was sufficient to reconstitute TRAP activity. Retroviral vector-control cells were generated with the same parental ALT cells, but infected with an empty retroviral vector not encoding for any telomerase components. These vectorcontrol cells were selected using the same antibiotic selection protocol and pooled as a polyclonal mass culture. IC denotes the signals from the internal control for PCR amplification. and SUSM-1 cell models. A total of 25 ALT cells were seeded in every well of a 96-well culture plate. Following 3 weeks of continuous growth in normal culture conditions, the tissue culture plates were stained with methylene blue for growth measurement in each well. Allowing cell colonies to grow in normal culture conditions for 3 weeks ensured that each culture will reach growth confluency, regardless of differences in growth rate. Therefore, if the 25 seeded cells were successful in repopulating the growth surface, we should be able to score the plate as positive. Recovery from low cell seeding number was robust in ALT cells expressing telomerase activity and less so in control ALT cells or cells that expressed either TERT or TER components alone (Figures 3b and c) .
Telomerase promotes growth advantages in an intrinsic manner Telomerase expression allowed ALT cells to recover from low seeding density. This can be explained by an increased ability of telomerase-positive ALT cells to conduct intercellular cross-talk through cytokine secretion, thereby supporting population growth. An alternative explanation could be that telomerase expression confers an intrinsic ability in ALT cells to promote their own growth. To differentiate between these possibilities, we performed coculture experiments using cell culture transwell inserts fitted with polyethylene terephthalate membrane, with a 0.4-mm pore size, which allowed the free exchange of culture media, growth factors, cytokines and metabolites between the two growth surfaces, but did not permit the migration of cells. Vector control ALT cells were seeded onto the insert surface, and telomerase-expressing ALT cells (experimental group), or the same vector control ALT cells (negative control), were cultured within the wells (Figure 4 ). The growth profiles of vector control ALT cells were monitored by counting cell numbers daily following the start of the coculture experiment for 6 consecutive days. Cells were fed every 3 days to limit any flushing of secreted cytokines, but with enough frequency to ensure that buildup of metabolites or depletion of exogenous growth factors would not interfere with normal growth. Comparing the growth curves of different combinations of cocultured cells in three ALT cell models, we did not detect any difference in growth rates of vector control cells when coculturing with telomerase-expressing cells, or with the same ALT cells in the bottom wells. Similarly, coculturing with vector control cells did not change the fast growth kinetics of telomerase-expressing ALT cells (Supplementary Figure 3) . From this experiment, we concluded that the observed increase in cell Telomerase activity was shown to confer growth advantages to low seeding concentrations in both ALT lines. These experiments were repeated five times (a) and three times (b) and (c) respectively; error bars represent standard deviations. Statistical significances between each comparison group were noted by P-values.
growth of telomerase-expressing ALT cells is not a function of increased cellular cross-talk, at least not in the form of released cytokines or paracrines that could pass through the polyethylene terephthalate membrane and influence the growth rate of parental ALT lines.
Telomerase confers anchorage-independent growth advantages to ALT cells Characterization of the pattern of cell growth under different culture conditions, led to the observation of an increased capacity of telomerase-expressing ALT cells to resume normal growth following the disruption of culture vessel adherence by trypsinization and replating. This growth advantage of telomerase-expressing ALT cells could reflect an increased ability to sustain normal growth in a manner independent of anchorage to plastic growth surface. To examine this possibility, we employed the soft agar growth assays to test the ability of telomerase expression to promote anchorage-independent growth. Transformed cells acquire the ability to grow as colonies in semisolid media such that anchorage-independent growth is considered one of the phenotypically recognizable characteristics of cellular transformation (O'Hayer and Counter, 2006). As ALT cells are transformed human cells, they do exhibit robust anchorage-independent growth. When we tested the contribution of forced telomerase activity expression on anchorage-independent growth with the CFU assay, we observed a significant advantage of telomerase-positive ALT cells to promote growth independently of anchorage. VA13 and GM00847 ALT lines exhibited an increased capacity for CFU formation in a manner dependent on telomerase activity ( Figure 5 ). Qualitatively, the colonies from telomerase-positive ALT cells were much larger at the end of the 2-week incubation, over and beyond our threshold positive signal of 50 mm colony sizes. This last observation is likely reflective of a gain in the rate of cell cycle progression (see below as well as Figures 7a and b) , cumulative over the 2-week period of CFU growth. (DN710), which did not have reverse transcriptase activity, we included the amino-terminal (NDAT92 and NDAT122) and carboxy-terminal (CDAT1127) DAT TERT mutants, which are catalytically active but cannot support telomere maintenance, due to telomere localization defects (Armbruster et al., 2001 (Armbruster et al., , 2004 Banik et al., 2002) , as well as primer-template positioning dysfunctions (Lee et al., 2003) . The DAT mutants were previously reported to retain the capacity to promote the non-canonical functions of TERT in chromatin remodeling and are therefore competent to promote DNA-damage repair, despite defects in their canonical TERT functions . We also included three telomerase-RNA-binding-defective TERT mutants (FYAA561, RBD386 and RBD512; Etheridge et al., 2002) . Although our earlier experiments demonstrated that the expression of both TERT and TER components were necessary to support telomerase growth-promoting functions in ALT cells, we could not rule out the possibility that these two telomerase components were working independently. VA13 cells lines stably expressing these seven TERT mutants were created by retroviral infection and selected with the appropriate antibiotics. TRAP activity profiles confirmed the positive expression of the TERT mutants (Figure 6a) .
We first characterized the growth of VA13 cells expressing TERT mutants. In agreement with our previous data, VA13 cells with fully functional telomerase activity (wild-type (WT)-TERT and TER) exhibited a growth advantage over that of the vector-control cells. All seven TERT mutants exhibited growth kinetics similar to VA13 vector control cells, indicating that the presence of WT telomerase activity is essential for the observed gain in growth advantages (Figure 6b ). We then tested these VA13 TERT mutant cells' ability to support anchorage-independent growth. CFU assays were performed as stated, and the number of positive colonies were scored after a 2-week incubation. In agreement with our earlier data, the expression of WT-TERT together with recombinant TER conferred a significant advantage to anchorage-independent growth of VA13 cells. Again, none of the seven TERT mutants exhibited any increase in positive CFU scores over the vector-control cells (Figure 6c ). We concluded from these experiments that the fully functional WT telomerase activity was obligate to promote the growth advantages observed in the VA13 ALT cell model.
Telomerase promotes efficient progression through the G2 and cell division phases of the cell cycle Telomerase-positive ALT cells exhibited an increase in growth kinetics over a period of 6 days in culture. An increase in total cell population could result from an increase in cell proliferation or from a reduction in population loss through cell death. As trypan blue dye exclusion staining of ALT cells did not show substantial differences between telomerase-positive and -negative populations shortly following cell seeding (Supplementary Figure 4) , we elected to characterize cell cycle progression of the ALT model VA13 cells.
We analyzed cell cycle progression with metabolic pulse-label experiments. A short pulse (1 h) of bromodeoxyuridine (BrdU) incubation labeled cells that were entering the DNA synthesis (S) phase of the cell cycle. Cell cycle progression following BrdU pulse label was monitored using propidium iodide staining for genomic DNA content. Timed harvest of BrdU pulse-labeled VA13 cells in the presence or absence of telomerase activity did not reveal a substantial difference in the population of cells that were labeled, nor did we detect any difference in the time course of these isogenic cell lines passing through S phase and entering the gap 2 (G2) phase of the cell cycle (compare BrdU-positive/Sphase staining profiles of VA13TERT/TER cells with VA13-vector-control cells at the 2-h time point following pulse labeling, Figure 7a ). In contrast, telomerase-positive VA13 cells pass through G2 and mitosis with faster kinetics than their telomerase-negative counterparts. The first detectable population of telomerase-positive VA13 GM00847 ALT cells expressing telomerase components were subjected to anchorage-independent growth by seeding onto DMEMagarose plates. Following a 2-week incubation, colonies over 50 mm in diameter were scored as positive. Reconstitution of telomerase activity correlates with the increased ability of ALT cells to grow in an anchorage-independent manner. VA13 cells expressing either TERT or TER alone did not have significantly higher CFU counts than vector-control cells. Experiments were repeated at least three times, and error bars represent standard deviation. SUSM-1 cells did not form normal suspended colonies in DMEM-agarose plates and were excluded from this comparison. cells completed the cell division phase of the cell cycle as soon as 6 h following BrdU pulse labeling, in contrast to a similar size peak observed in the telomerase-negative VA13 cells at later time points, after BrdU labeling (Figures 7a and b) . This gain in efficiency was consistently observed at each subsequent time point of our experiment (comparing G1 peak heights between VA13TERT/TER cells and VA13-vector-control cells, These data show that telomerase expression confers a modest advantage for VA13 cells passing through the G2 and mitosis phases of the cell cycle. Although telomerase-positive VA13 cells showed a modest gain in cell cycle kinetics per cell division, the cumulative gain over a longer period of growth would be substantial. These data are supported by a separate experiment using chemically (aphidicolin) synchronized VA13 cells (Supplementary Figure 5) .
Discussion
The prevalence of reactivating telomerase for telomere length maintenance versus homologous recombinationbased telomere maintenance in human tumors suggests that telomerase functions go beyond telomere repair in promoting tumor growth (Blasco, 2002; Chang and DePinho, 2002; Stewart et al., 2002) . Forced telomerase expression in ALT models confers growth advantages under all tested conditions, including limited cellular cross-talk, low seeding number and in anchorageindependent growth assays. This growth promotion is only apparent with the inactivation of growth inhibitory signals and the absence of tumor suppressor gene functions, as constitutive telomerase activation in primary human cells did not result in changes to their growth characteristics (Kiyono et al., 1998; Harley, 2002) .
Telomerase downregulation in human primary fibroblasts is associated with a decreased tolerance to ionizing radiation (Goytisolo et al., 2000; Wong et al., 2000; Nakamura et al., 2005) . In a human primary fibroblast model, RNA-interference-dependent knockdown of endogenous telomerase expression suggested that TERT expression contributes to the chromatin architecture in a manner independent of telomere maintenance. Functional rescue of TERT knockdown cells was accomplished using the DAT mutants but not the catalytically dead TERT variant , suggesting that this novel telomerase function is working in a non-canonical manner, separate from its role in telomere length maintenance. Corroborating this observation, functional segregation of TERT has been previously described in mouse as well as human cell models (Chang and DePinho, 2002; Dong et al., 2005) . In contrast, our mutagenesis studies showed that none of the tested TERT mutants, including the same DAT mutants and other RNA-binding-deficient TERT variants, support advantageous growth kinetics, nor do they promote anchorage-independent growth in the VA13 ALT model. Our data indicate that WT-TERT, with its associated telomerase activities, is obligate in promoting oncogene-dependent growth in ALT cells, suggesting the involvement of telomerase's canonical function. We contend that telomerase-dependent growth promotion in ALT cells is functionally separate from previously reported non-canonical TERT-mediated maintenance of chromatin architecture and DNA repair in normal human cells.
Anoikis is a specialized apoptosis program that occurs in the absence of attachment to the extracellular growth matrix. Anoikis is considered a tumor-suppressive mechanism by virtue of preventing the migration of cells to inappropriate locations (Frisch and Screaton, 2001; Horbinski et al., 2010) . Although the molecular mechanisms underlying anoikis have not been elucidated in detail, the aberrant expression of an oncogene or tumor suppressor gene can cause resistance to anoikis, thereby contributing substantially to malignancy. Both VA13 and GM00847 ALT cells exhibit anchorage-independent growth properties, and our data showed that this anchorage-independent growth capacity was further augmented with the expression of telomerase activity. Although there is currently no satisfactory molecular theory on how telomerase activity contributes to anchorage-independent growth, the observation that WT-TERT functions are necessary for this growth suggests that this could be telomere structure dependent. Alternatively, telomerase could promote cell survival by affecting the expression of anti-anoikis factors. In support of this hypothesis, a transcriptome study done by Smith et al. (2003) demonstrated that the ectopic expression of telomerase in human mammary epithelial cells reduced the need for exogenous mitogens for cellular proliferation, which correlates with the induction of the expression of cell growth and survival factors. Additionally, TERT has recently been shown to function as a transcriptional coactivator of the b-catenin transcriptional complex in mice (Park et al., 2009) . As anoikis can be reversed by the acquisition of anchorage independence or cell motilityrelated factors (Nagaprashantha et al., 2011) , the expression levels of these cellular proteins could be measured in ALT cells before and after telomerase replacement. Our laboratory is actively pursuing this line of work.
The three ALT cell models in our study have heterogeneous and long telomere lengths (445 kb, Supplementary Figure 1) , implying that the observed improvement in growth characteristics of telomerasepositive ALT cells may not be due to telomere length regulation. Although improved growth in telomerasepositive ALT cells may not be telomere length dependent, it may, however, be related to the resolution or the repair of telomere structures following DNA replication. This is probably a related function of telomerase at the telomeres, underappreciated but still part of the enzyme's canonical function of telomere maintenance. ALT cells can efficiently maintain telomere length in the absence of telomerase; however, little is known about the maintenance of telomere end structures by the ALT mechanism. Telomerase is reported to associate with specific exonuclease activities (Huard and Autexier, 2004; Oulton and Harrington, 2004) ; following telomere repeat synthesis, this nuclease activity could contribute to the correct and efficient generation of telomeric DNA end structure. The ensured timely resolution and reformation of the higher-order telomere loop structures predict the efficient progression of the cell cycle through G2 and mitosis phases of the cell cycle, illustrated by our cell cycle analysis data. Further experimentation to probe ALT cells' telomere structure will provide a more detailed sequence of events to illuminate TERT's role in this specific aspect of telomere biology.
Stochastic loss of complete telomere loops is also observed in ALT cells (Wang et al., 2004) , creating signal-free ends that resemble random double-stranded DNA breaks. The presence of telomerase is necessary to 'repair' this stochastic telomere loop loss and reduce the cell death associated with activation of the corresponding DNA damage response pathways (Verdun et al., 2005; Verdun and Karlseder, 2006) . It is also plausible that telomerase activity could promote efficient repair following complete telomere loop excision in ALT cells, leading to a gain in efficiency of progression through specific phases of the cell cycle. Indeed, ALT-dependent homologous recombination resulted in heterogeneous telomeres within the cell population, and it has been previously shown that forced expression of human telomerase activity can limit the number of telomere DNA repeat signal-free ends in ALT cells (Fakhoury et al., 2010) .
Over 85% of human cancers express telomerase (Shay and Bacchetti, 1997) . The use of telomerase inhibitors in cancer chemotherapy was dissuaded by a perceived long lag time for telomere attrition (Hahn et al., 1999b) . Our data indicate that telomerase expression improves the overall fitness of oncogenic-transformed human cells in a manner independent of telomere length. This, together with recent data connecting telomerase activity and DNA repair capacity should encourage a closer evaluation of telomerase inhibition chemotherapy.
Materials and methods

Mutagenesis and construction of expression vectors
Retroviral expression vectors pBabehygro-Flag-TERT and pBabepuro-U3hTER were previously described (Wong and Collins, 2006) . TERT mutants NDAT92, NDAT122, CDAT1127 and DN710 have been described elsewhere . Other TERT mutants were first generated with DpnI mutagenesis in pCite4A and subcloned into the pbabehygro expression vector with the NdeI and SalI restriction sites. Successful mutagenesis and expression vector fidelity were confirmed with sequencing.
Cell culture Three ALT cell lines, WI-38-VA13, SUSM-1 (both obtained as gifts from the laboratory of Kathleen Collins) and GM00847 (from the Coriell Cell Repository, Camden, NJ, USA), were grown in Dulbecco's minimum essential media (DMEM) supplemented with 5% fetal bovine serum and penicillin/ streptomycin at 37 1C under 5% CO 2 .
Retroviral infection procedure was essentially as described previously (Wong and Collins, 2006) . ALT cells surviving the antibiotic selection were pooled together as polyclonal populations.
For coculture experiments, transwell inserts were equilibrated with media before cell seeding. At 24 h time point intervals, cells growing on the transwell inserts, as well as the corresponding influencer cells, were trypsinized and total cell counts were obtained with a Coulter Counter (Beckman Coulter Inc., Brea, CA, USA).
For limited dilution cell growth, the GM00847 cell line was tested with a serial dilution of seeded cells in five separate experiments. For the other two ALT cell lines (VA13 and SUSM-1), cells were first tested with a serial dilution experiment to determine the number of seeded cells necessary in the whole-plate assay. Following this determination, ALT cells with and without telomerase were seeded in 96-well plates at a predetermined number of cells per well (25 cells/well). After 3 weeks of incubation, culture plates were stained with 0.2% methylene blue in 50% ethanol, washed and solubilized in 1% SDS. Colorimetric readings at 595 nm were conducted with a standard spectrophotometric plate reader. We scored the well as having positive growth when the absorbance reading was 0.115 over the background value, which indicated robust cell growth.
TRAP and colony-forming unit assay Telomerase activity was measured by the TRAP as described (Tamakawa et al., 2010) . Serial dilutions of cell extracts, normalized to total protein concentration were used as the enzyme source.
The colony-forming unit (CFU) assay was performed essentially as described (Tamakawa et al., 2010) . Seeded cells were allowed to grow into individual colonies for 2 weeks at 37 1C under 5% CO 2 . Colonies were counted as positive when their size exceeded 50 mm.
Cell cycle analysis by BrdU pulse label BrdU pulse labeling of actively cycling cells: at 36 h after plating, VA13 cells were treated with 10 mM BrdU in supplemented DMEM and pulse labeled for 1 h. Following the BrdU pulse, cells were washed with phosphate-buffered saline and replaced with fresh media. BrdU-labeled cells were harvested by trypsinization and fixed with EtOH at designated time points. AntiBrdU immunostaining and propidium iodide nucleic acid labeling were conducted according to manufacturer's protocol (Becton Dickinson, Franklin Lake, NJ, USA), with the addition of RNAse to remove non-specific signals (RNAse treatment is part of the manufacturer's protocol). Labeled cells were sorted using the BD Calibur flow cytometer (UBC Biomedical Research Center), with gating for BrdU-positive cells. Fluorescenceactivated cell sorting data were analyzed with Cell Quest (Becton Dickinson) and Flow Jo (Tree Star Inc., Ashland, OR, USA) software.
